Medicine

Elinore Kaufman of the Perelman School of Medicine says that society must come to an understanding about why the systems put in place to protect children aren’t working.

The Penn Colton Center for Autoimmunity at the Perelman School of Medicine is noted for its experimental and theoretical studies in immunology.

An Op-Ed by nurse practitioner student Stefanie Orrico argues for the establishment of a minimum nurse-to-patient ratio policy, featuring a quote from Karen Lasater of the School of Nursing.

Deborah Silverstein of the School of Veterinary Medicine discusses the prevalence of dog flu this winter.

Linda Aiken of the School of Nursing says that complexity and lack of transparency in hospital-supplied data necessitates surveys of staff to figure out the truth.

Aimee Payne of the Perelman School of Medicine notes the positive potential of a new skin gel in counteracting a rare and severe genetic skin disease.

Bruce Levine of the Perelman School of Medicine says that the latest results of Crispr gene editing in a cancer patient have showcased the best possible clinical outcome thus far.

Jennifer Reid of the Perelman School of Medicine writes that mental health clinicians have a valuable opportunity to harness the power of social media for good. 

Carl June of the Perelman School of Medicine says that off-the-shelf CAR-T cell therapies using CRISPR would be a game-changer.

Peroxitech, a biopharmaceutical company co-founded by Aron Fisher of the Perelman School of Medicine and Sheldon Feinstein, formerly of Penn Medicine, has closed a $25 million equity financing for its new lead drug candidate.